FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug
2 years ago
34
ARTICLE AD BOX
Federal regulators are putting off a decision on Eli Lilly’s potential Alzheimer’s treatment with an unusual request to have an advisory committee examine the drug